Robert Peter Kadlec

Insider Reports History

Location
C/O Mink Therapeutics 149 Fifth Avenue, New York, NY
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Peter Kadlec:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Director Common Stock 17.9K $248K $13.86 Sep 2, 2025 Direct
MiNK Therapeutics, Inc. Director Stock Option 41.7K Oct 30, 2024 Direct
MiNK Therapeutics, Inc. Director Stock Option (Right to Buy) 3.23K Sep 9, 2025 Direct

Insider Reports Filed by Robert Peter Kadlec

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INKT MiNK Therapeutics, Inc. Sep 9, 2025 1 $0 4 Sep 11, 2025 Director
INKT MiNK Therapeutics, Inc. Sep 2, 2025 1 $13.5K 4 Sep 3, 2025 Director
INKT MiNK Therapeutics, Inc. Jun 2, 2025 1 $13.5K 4 Jun 4, 2025 Director
INKT MiNK Therapeutics, Inc. Mar 3, 2025 1 $13.5K 4 Mar 5, 2025 Director
INKT MiNK Therapeutics, Inc. Oct 30, 2024 2 $8.97K 4 Dec 9, 2024 Director
INKT MiNK Therapeutics, Inc. Oct 30, 2024 0 $0 3 Dec 9, 2024 Director